| 1 |
27229742 | A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study). | 2016 |
1 |
| 2 |
27468920 | Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study). | 2016 Sep |
1 |
| 3 |
28133330 | [A Case of Successful Treatment of Liver Metastases from Gastric Cancer with Chemotherapy]. | 2016 Nov |
1 |
| 4 |
26109630 | Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05). | 2015 Sep |
2 |
| 5 |
24156021 | Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer. | 2013 Aug |
4 |
| 6 |
24231711 | [A case of liver metastasis of primary duodenal cancer effectively treated with docetaxel therapy]. | 2013 Nov |
1 |
| 7 |
22740861 | Sequential irinotecan hydrochloride/S-1 for S-1-resistant inoperable gastric cancer: A feasibility study. | 2012 Jan |
5 |
| 8 |
22777333 | Safety verification trials of mFOLFIRI and sequential IRIS + bevacizumab as first- or second-line therapies for metastatic colorectal cancer in Japanese patients. | 2012 |
1 |
| 9 |
21499002 | [A case report of primary duodenal adenocarcinoma responding to chemotherapy with S-1 and irinotecan]. | 2011 Apr |
1 |
| 10 |
19417717 | Effects of oral administration of S-1 on the pharmacokinetics of SN-38, irinotecan active metabolite, in patients with advanced colorectal cancer. | 2009 Jun |
9 |
| 11 |
19920821 | Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer. | 2009 Dec 15 |
4 |
| 12 |
18281776 | [Two cases with recurrent non-small cell lung cancer successfully treated with cisplatin and S-1]. | 2008 Feb |
1 |
| 13 |
19343150 | Advanced gastric cancer: an update and future directions. | 2008 Jul |
1 |
| 14 |
16619577 | Feasibility study of biweekly CPT-11 plus CDDP for S-1- and paclitaxel-refractory, metastatic gastric cancer. | 2006 Mar-Apr |
2 |
| 15 |
16897968 | [Antitumor activity and function of S-1, a new oral tegafur-based formulation]. | 2006 Jun |
1 |
| 16 |
16897973 | [Clinical development of S-1 (TS-1) for advanced gastric cancer]. | 2006 Jun |
1 |
| 17 |
16897977 | [Combination chemotherapy of S-1 +CPT-11 (q 4-5 w) for metastatic gastric cancer]. | 2006 Jun |
1 |
| 18 |
16897987 | [The current evidence of S-1 and irinotecan hydrochloride combination chemotherapy with tri-weekly schedule]. | 2006 Jun |
1 |
| 19 |
16897989 | [Combination chemotherapy with S-1 plus CPT-11 for patients with advanced or recurrent colorectal cancer]. | 2006 Jun |
1 |
| 20 |
17015060 | Effect of S-1 on pharmacokinetics of irinotecan in a patient with colorectal cancer. | 2006 Oct |
1 |
| 21 |
17106441 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. | 2006 Dec 18 |
1 |
| 22 |
15757419 | Available options in chemotherapy for advanced gastric cancer: the current developments in Japan. | 2005 Feb |
1 |
| 23 |
15075664 | The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors. | 2004 Feb |
1 |
| 24 |
12775012 | S-1 in gastric cancer: a comprehensive review. | 2003 |
1 |